Psyence Biomedical Common Stock

Psyence Biomedical (PBM) currently reports a common stock of $69M as of September 2025. That compares with $53M in the prior-year period — up 30.1% year over year. Use the charts on this page to explore Psyence Biomedical's common stock history and peer comparisons.

Psyence Biomedical's common stock increased from $53M to $69M — a 30.1% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Psyence Biomedical reported $69M in common stock as of September 2025. That compares with $53M in the prior-year period — up 30.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $69M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Psyence Biomedical, and consider following PBM for alerts when major investors trade the stock.